2016
DOI: 10.3389/fphys.2016.00222
|View full text |Cite
|
Sign up to set email alerts
|

The Roles of Acidosis in Osteoclast Biology

Abstract: The adverse effect of acidosis on the skeletal system has been recognized for almost a century. Although the underlying mechanism has not been fully elucidated, it appears that acidosis acts as a general stimulator of osteoclasts derived from bone marrow precursors cells and enhances osteoclastic resorption. Prior work suggests that acidosis plays a significant role in osteoclasts formation and activation via up-regulating various genes responsible for its adhesion, migration, survival and bone matrix degradat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
42
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 57 publications
(47 citation statements)
references
References 103 publications
(137 reference statements)
1
42
0
1
Order By: Relevance
“…OGR1 does not desensitize and is the only proton-sensing GPCR coupling to changes in [Ca 2+ ] i [14,27], which determine a plethora of physiological as well as underlie pathological processes. OGR1 affects a number of distinct cellular processes and, in light of our findings, its role in enamel formation [28] and bone development [29][30][31] is particularly intriguing: enamel and bone are the hardest materials in the human body, and enamel formation and bone development both require cycles of extracellular acidification [32,33].…”
Section: Discussionmentioning
confidence: 71%
See 1 more Smart Citation
“…OGR1 does not desensitize and is the only proton-sensing GPCR coupling to changes in [Ca 2+ ] i [14,27], which determine a plethora of physiological as well as underlie pathological processes. OGR1 affects a number of distinct cellular processes and, in light of our findings, its role in enamel formation [28] and bone development [29][30][31] is particularly intriguing: enamel and bone are the hardest materials in the human body, and enamel formation and bone development both require cycles of extracellular acidification [32,33].…”
Section: Discussionmentioning
confidence: 71%
“…Extracellular acidification and increases in tissue stiffness are also associated with aging [33,34] and accompany and promote disease progression [35][36][37]. This places OGR1 in an exceptional position, as it is synergistically activated by both and hence sensitive to even small changes.…”
Section: Discussionmentioning
confidence: 99%
“…The formation of osteoclasts in culture was also found to be a dominant end effect of acidosis, as Trap5b expression was similar in both top and bottom sections of ch‐ch constructs and the differences in pO 2 was negligible. Also shown in other literatures, acidosis was reported to enhance osteoclast formation in cats (Muzylak, Arnett, Price, & Horton, ) and regulates survival of mature rat osteoclast (Pereverzev et al, ; Yuan et al, ). Additionally, the elevated expression of sclerostin ( Sost ) would have also induced Trap5b expression via the RANKL‐dependent pathway for bone remodelling and resorption (Weivoda, Youssef, & Oursler, ; Wijenayaka et al, ).…”
Section: Discussionmentioning
confidence: 60%
“…Also shown in other literatures, acidosis was reported to enhance osteoclast formation in cats (Muzylak, Arnett, Price, & Horton, 2007) and regulates survival of mature rat osteoclast (Pereverzev et al, 2008;Yuan et al, 2016). Additionally, the elevated expression of sclerostin (Sost) would have also induced Trap5b expression via the RANKL-dependent pathway for bone remodelling and resorption (Weivoda, Youssef, & Oursler, 2017;Wijenayaka et al, 2011).…”
Section: Discussionmentioning
confidence: 73%
“…In people with osteoporosis, bone loss is due to increased osteoclast activity, and decreased osteoblastic bone formation cannot keep pace with bone resorption ( 4 , 5 ). Most existing therapeutics for osteoporosis are antiresorptive drugs, such as bisphosphonates, and anabolic medications, including denosumab and teriparatide ( 6 ).…”
Section: Introductionmentioning
confidence: 99%